Found: 27
Select item for more details and to access through your institution.
Effect of intensive versus standard blood pressure control on cerebral blood flow in SPRINT: Neuroimaging / evaluating treatments.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042155
- By:
- Publication type:
- Article
Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study.
- Published in:
- Cardiology & Therapy, 2018, v. 7, n. 2, p. 173, doi. 10.1007/s40119-018-0117-y
- By:
- Publication type:
- Article
Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.
- Published in:
- European Heart Journal, 2019, v. 40, n. 42, p. 3486, doi. 10.1093/eurheartj/ehz392
- By:
- Publication type:
- Article
Telmisartan plus hydrochlorothiazide (80/25 mg) has a greater antihypertensive effect than valsartan plus hydrochlorothiazide (160/25 mg) in patients with stage 1 and 2 hypertension
- Published in:
- 2005
- By:
- Publication type:
- Abstract
An 8-week, double-blind, placebo-controled, multicenter, Ambulatory Blood Pressure Monitoring (ABPM) study of Teveten (Eprosartan Mesylate) 600mg and 1200mg QD in patients with essential hypertension
- Published in:
- 2005
- By:
- Publication type:
- Abstract
A 13-week, double-blind, placebo-controlled, parallel, multicenter study of eprosartan mesylate given in titrated doses of 600mg or 1200 mg once daily in patients with isolated systolic hypertension
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 4, p. 380, doi. 10.1001/jamaneurol.2022.0074
- By:
- Publication type:
- Article
Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2014, v. 8, n. 1, p. 12, doi. 10.1177/1753944713520062
- By:
- Publication type:
- Article
Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2012, v. 6, n. 4, p. 149, doi. 10.1177/1753944712452190
- By:
- Publication type:
- Article
Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2010, v. 4, n. 6, p. 349, doi. 10.1177/1753944710387629
- By:
- Publication type:
- Article
Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2010, v. 4, n. 4, p. 209, doi. 10.1177/1753944710374745
- By:
- Publication type:
- Article
Flushing Assessment Tool (FAST).
- Published in:
- Clinical Drug Investigation, 2009, v. 29, n. 4, p. 215, doi. 10.2165/00044011-200929040-00001
- By:
- Publication type:
- Article
Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Baseline blood pressure control in Hispanics: characteristics of Hispanics in the Systolic Blood Pressure Intervention Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy of Amlodipine and Olmesartan Medoxomil in Hypertensive Patients With Diabetes and Obesity.
- Published in:
- Journal of Clinical Hypertension, 2011, v. 13, n. 6, p. 422, doi. 10.1111/j.1751-7176.2010.00422.x
- By:
- Publication type:
- Article
Effects of the Angiotensin II Receptor Blockers Telmisartan vs Valsartan in Combination With Hydrochlorothiazide 25 mg Once Daily for the Treatment of Hypertension.
- Published in:
- Journal of Clinical Hypertension, 2006, v. 8, n. 9, p. 626, doi. 10.1111/j.1524-6175.2006.05411.x
- By:
- Publication type:
- Article
Efficacy and Safety of Olmesartan Medoxomil and Hydrochlorothiazide Compared with Benazepril and Amlodipine Besylate.
- Published in:
- American Journal of Cardiovascular Drugs, 2007, v. 7, n. 4, p. 361, doi. 10.2165/00129784-200707050-00006
- By:
- Publication type:
- Article
Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial.
- Published in:
- JGIM: Journal of General Internal Medicine, 2022, v. 37, n. 15, p. 3797, doi. 10.1007/s11606-022-07753-5
- By:
- Publication type:
- Article
Metabolic issues in the antihypertensive and lipid-lowering heart attack trial study.
- Published in:
- Current Hypertension Reports, 2004, v. 6, n. 2, p. 106, doi. 10.1007/s11906-004-0084-7
- By:
- Publication type:
- Article
Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.
- Published in:
- Integrated Blood Pressure Control, 2014, v. 7, p. 61, doi. 10.2147/IBPC.S50954
- By:
- Publication type:
- Article
Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination.
- Published in:
- Integrated Blood Pressure Control, 2011, v. 4, p. 73
- By:
- Publication type:
- Article
Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants.
- Published in:
- American Journal of Nephrology, 2020, v. 51, n. 10, p. 797, doi. 10.1159/000509978
- By:
- Publication type:
- Article
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
FGF23, Frailty, and Falls in SPRINT.
- Published in:
- Journal of the American Geriatrics Society, 2021, v. 69, n. 2, p. 467, doi. 10.1111/jgs.16895
- By:
- Publication type:
- Article
Efficacy/Safety of olmesartan medoxomil versus losartan potassium in naïve versus previously treated subjects with hypertension.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Efficacy/Safety of Olmesartan Medoxomil Versus Losartan Potassium in Naïve Versus Previously Treated Subjects With Hypertension.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 6, p. 524, doi. 10.1007/s12325-012-0029-5
- By:
- Publication type:
- Article